Viewing Study NCT02374333


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2026-03-03 @ 5:04 PM
Study NCT ID: NCT02374333
Status: COMPLETED
Last Update Posted: 2021-09-23
First Post: 2015-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy
Sponsor: University of Pennsylvania
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphocytic Leukemia View
None Diffuse Large Cell Lymphoma View
Keywords: